急性心肌梗死期间的静脉β受体阻滞剂治疗 - Suppr | 超能文献

Intravenous beta-blockade during acute myocardial infarction.

出版信息

Lancet. 1986 Jul 12;2(8498):79-80.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Intravenous beta-blockade during acute myocardial infarction.急性心肌梗死期间的静脉β受体阻滞剂治疗

Lancet. 1986 Jul 12;2(8498):79-80.

2

[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].心肌梗死后长期使用β-肾上腺素能阻滞剂的治疗价值

Vutr Boles. 1984;23(3):16-25.

3

Anti-dysrhythmic treatment in acute myocardial infarction.急性心肌梗死的抗心律失常治疗

Lancet. 1979 Jan 27;1(8109):193-4.

4

[Treatment with beta-blockers in patients with acute coronary syndrome].[急性冠状动脉综合征患者使用β受体阻滞剂的治疗]

Nihon Rinsho. 1998 Oct;56(10):2612-6.

5

A review of acute-phase beta-blocker trials in patients with myocardial infarction.心肌梗死患者急性期β受体阻滞剂试验综述。

Circulation. 1983 Jun;67(6 Pt 2):I21-5.

6

Use of beta adrenoceptor blockade during and after acute myocardial infarction.急性心肌梗死期间及之后使用β肾上腺素能受体阻滞剂。

Annu Rev Med. 1986;37:415-25. doi: 10.1146/annurev.me.37.020186.002215.

7

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.45852例急性心肌梗死患者早期静脉注射后口服美托洛尔：随机安慰剂对照试验

Lancet. 2005 Nov 5;366(9497):1622-32. doi: 10.1016/S0140-6736(05)67661-1.

8

Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol.

Lancet. 1984 Oct 20;2(8408):883-6. doi: 10.1016/s0140-6736(84)90651-2.

9

Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Lancet. 1986 Jul 12;2(8498):57-66.

10

Early intravenous beta blockade in acute myocardial infarction.急性心肌梗死早期静脉应用β受体阻滞剂

Postgrad Med. 1988 Feb 29;Spec No:90-5.

引用本文的文献

1

[How many beta-receptor blockers does the physician need?].医生需要多少种β受体阻滞剂？

Klin Wochenschr. 1987 Mar 16;65(6):289-95. doi: 10.1007/BF01773455.